Literature DB >> 9845323

Neuronal expression of fractalkine in the presence and absence of inflammation.

W J Schwaeble1, C M Stover, T J Schall, D J Dairaghi, P K Trinder, C Linington, A Iglesias, A Schubart, N J Lynch, E Weihe, M K Schäfer.   

Abstract

Fractalkine is the only as yet known member of a novel class of chemokines. Besides its novel Cys-X-X-X-Cys motif, fractalkine exhibits features which have not been described for any other member of the chemokine family, including its unusual size (397 amino acids human, 395 mouse) and the possession of a transmembrane anchor, from which a soluble form may be released by extracellular cleavage. This report demonstrates the abundant mRNA and fractalkine protein expression in neuronal cells. The neuronal expression of fractalkine mRNA is unaffected by experimentally induced inflammation of central nervous tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845323     DOI: 10.1016/s0014-5793(98)01384-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

2.  The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.

Authors:  A D Lucas; N Chadwick; B F Warren; D P Jewell; S Gordon; F Powrie; D R Greaves
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 3.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

4.  Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas.

Authors:  Gael Fenhalls; Liesel Stevens; Juanita Bezuidenhout; Gillian E Amphlett; Ken Duncan; Philip Bardin; Pauline T Lukey
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12.

Authors:  Lucia Labrada; Xiao Huan Liang; Wei Zheng; Christine Johnston; Beth Levine
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.

Authors:  Dan Sunnemark; Sana Eltayeb; Maria Nilsson; Erik Wallström; Hans Lassmann; Tomas Olsson; Anna-Lena Berg; Anders Ericsson-Dahlstrand
Journal:  J Neuroinflammation       Date:  2005-07-29       Impact factor: 8.322

7.  Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.

Authors:  C A Haskell; W W Hancock; D J Salant; W Gao; V Csizmadia; W Peters; K Faia; O Fituri; J B Rottman; I F Charo
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

8.  Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ.

Authors:  S Strobel; E Grünblatt; P Riederer; H Heinsen; T Arzberger; S Al-Sarraj; C Troakes; I Ferrer; Camelia Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2015-01-18       Impact factor: 3.575

9.  CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-β1.

Authors:  Giuseppe Sciumè; Alessandra Soriani; Mario Piccoli; Luigi Frati; Angela Santoni; Giovanni Bernardini
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

Review 10.  Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery.

Authors:  Changhong Xing; Eng H Lo
Journal:  Prog Neurobiol       Date:  2016-04-11       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.